News About: Pharm. Industry
Patent Expiration of Zanidip Will Bring Intense Competition Next Year
The pharmaceutical industry expects an increased level of competition among the domestic makers of first generics next year, as the patent for Zanidip (active ingredient: lercanidipine hydrochloride) will be expired i...
Cellbiotech Introduces Novel Anti-Hyperlipidemic Agent
Cellbiotech Co., a domestic biotechnology venture company, announced this week that it has successfully completed a pre-clinical animal study for a novel anti-hyperlipidemic agent known as PROLAC-T.
Jointly perform...
Kolon Wellcare to Expand W-Store Retail Outlets
Kolon Wellcare, the distribution unit of the Kolon group, plans to expand its franchise business of W-Store, a retail chain pharmacy designed and operated under a well-being concept, where the customers could purchase...
Velcade, Novel Anticancer Treatment, Now Available Under NHI Coverage
Janssen Korea announced this week that the company has completed the registration of Velcade (bortezomib) injection, a novel anticancer treatment, to the National Health Insurance (NHI) list of approved medications, a...
SK Launches Anticoagulant Agent in Domestic Market
SK Chemical and SK Pharma announced an official launching of Futhan inj. (active ingredient: nafamostat mesilate), a potent protease inhibitor originally developed by Torii Pharmaceutical of Japan, in the domestic mar...
Pfizer Korea Provides Increased Understanding Towards Lower Urinary Tract Symptom
Pfizer Korea recently held the Year 2005 LUTS (Lower Urinary Tract Symptom) Forum addressed to over 80 urology specialists from the nation's major general hospitals, in an effort to provide an in-depth understanding t...
Nicotine Replacement Products Now Available at Public Health Centers Nationwide
The recent price hike of the retail cigarette prices, along with the continuous anti-smoking policy and related campaign efforts exerted by the government, are giving new market opportunities for the pharmaceutical ma...
Shinpoong Makes Exclusive Licensing Agreement for Tesmilifene
Shinpoong Pharmaceutical Co. Ltd. announced last week that it made an exclusive domestic licensing agreement with YM BioSciences Inc.'s tesmilifene, a novel anticancer agent currently undergoing a multinational phase ...
InBioNET Submits Market Registration for Human Recombinant Interleukin-2
Upon completion of the domestic phase II clinical trial of interleukin-2 (product name: Geneleukin), a biopharmaceutical anticancer agent, InBioNET Inc. announced last week that it has submitted a market registration ...
Wholesale Practice of Discount List Selling Resurfaced
According to an inside industry source, a pharmaceutical wholesale practice of discount list selling has been resurfaced in the market, where the stated discounts are applicable to over 1,000 prescription-based ethica...
